Microscopic and functional changes observed with dynamic optical coherence tomography for severe refractory atopic dermatitis treated with dupilumab.

Marco ManfrediniSerena LiberatiSilvana CiardoLaura BonzanoMario GuantiJohanna ChesterShaniko KaleciGiovanni Pellacani

Published in: Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) (2020)

The study demonstrates that the clinical improvement of severe AD patients under dupilumab treatment is correlated with specific D-OCT changes of patients' lesional and clinically healthy skin.

Keyphrases

atopic dermatitis
end stage renal disease
optical coherence tomography
newly diagnosed
ejection fraction
chronic kidney disease
early onset